ACADIAN ASSET MANAGEMENT LLC - WUXI PHARMATECH CAYMAN INC ownership

WUXI PHARMATECH CAYMAN INC's ticker is WX and the CUSIP is 929352102. A total of 3 filers reported holding WUXI PHARMATECH CAYMAN INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of WUXI PHARMATECH CAYMAN INC
ValueSharesWeighting
Q3 2015$10,187,000
-67.9%
235,752
-68.6%
0.06%
-63.6%
Q2 2015$31,739,000
-39.4%
751,046
-44.4%
0.15%
-36.4%
Q1 2015$52,396,000
+17.7%
1,351,097
+2.2%
0.24%
+22.2%
Q4 2014$44,514,000
-2.0%
1,322,080
+1.9%
0.20%
-9.6%
Q3 2014$45,424,000
-32.0%
1,297,121
-36.1%
0.22%
-32.6%
Q2 2014$66,751,000
-26.9%
2,031,352
-18.0%
0.32%
-32.2%
Q1 2014$91,368,000
+255.6%
2,478,722
+270.2%
0.48%
+235.0%
Q4 2013$25,697,000
+411.0%
669,595
+264.8%
0.14%
+333.3%
Q3 2013$5,029,000183,5530.03%
Other shareholders
WUXI PHARMATECH CAYMAN INC shareholders Q4 2015
NameSharesValueWeighting ↓
Coupland Cardiff Asset Management LLP 449,361$15,737,00015.66%
Sloane Robinson LLP 120,000$4,202,0006.01%
Black Creek Investment Management Inc. 869,173$30,438,0003.50%
Grandeur Peak Global Advisors, LLC 358,385$12,551,0003.05%
THOMAS WHITE INTERNATIONAL LTD 538,212$18,848,0002.73%
ROSENBLUM SILVERMAN SUTTON S F INC /CA 88,460$3,098,0001.39%
Granite Point Capital Management, L.P. 70,000$2,451,0001.22%
COMMONWEALTH BANK OF AUSTRALIA 2,626,749$91,989,0001.19%
Apex Capital Management 1,048,531$36,720,0001.11%
Pier Capital, LLC 196,369$6,877,0001.10%
View complete list of WUXI PHARMATECH CAYMAN INC shareholders